Dietary d-allose ameliorates hepatic inflammation in mice with non-alcoholic steatohepatitis

Ryoko Yamamoto, Ayaka Iida, Ken Tanikawa, Hideki Shiratsuchi, Masaaki Tokuda, Toshiro Matsui, Tsuyoshi Nakamura

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Nonalcoholic steatohepatitis (NASH) is characterized by excess lipid accumulation and inflammation in hepatocytes. In this study, to provide insight into the preventive effects of d-allose, a rare sugar, on the onset of NASH, we designed animal experiments using male STAM mice treated with streptozotocin and fed a high-fat diet (HFD). Experiments were initiated when the mice reached 5 weeks of age and lasted 3 weeks. After the 3-week protocol, mice fed the HFD containing d-allose exhibited significantly decreased serum alanine aminotransferase levels, hepatic lipid accumulation and inflammation, and improved nonalcoholic fatty liver disease activity score compared to mice fed HFD without d-allose ( p < 0.05). Further, hepatic mRNA expression of sterol regulatory element binding protein-1 (Srebp-1) and monocyte chemotactic protein-1 (Mcp-1) was lower in mice fed d-allose. These results suggested that d-allose prevented NASH by blocking hepatic lipid accumulation and progressive inflammation.

Original languageEnglish
Pages (from-to)319-327
Number of pages9
JournalFood Science and Technology Research
Volume23
Issue number2
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

allose
Fatty Liver
Nutrition
Oils and fats
Lipids
inflammation
Inflammation
High Fat Diet
high fat diet
liver
Liver
mice
Fats
Sugars
lipids
Sterol Regulatory Element Binding Protein 1
Animals
Experiments
animal experimentation
Chemokine CCL2

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Food Science
  • Chemical Engineering(all)
  • Industrial and Manufacturing Engineering
  • Marketing

Cite this

Dietary d-allose ameliorates hepatic inflammation in mice with non-alcoholic steatohepatitis. / Yamamoto, Ryoko; Iida, Ayaka; Tanikawa, Ken; Shiratsuchi, Hideki; Tokuda, Masaaki; Matsui, Toshiro; Nakamura, Tsuyoshi.

In: Food Science and Technology Research, Vol. 23, No. 2, 01.01.2017, p. 319-327.

Research output: Contribution to journalArticle

Yamamoto, R, Iida, A, Tanikawa, K, Shiratsuchi, H, Tokuda, M, Matsui, T & Nakamura, T 2017, 'Dietary d-allose ameliorates hepatic inflammation in mice with non-alcoholic steatohepatitis', Food Science and Technology Research, vol. 23, no. 2, pp. 319-327. https://doi.org/10.3136/fstr.23.319
Yamamoto, Ryoko ; Iida, Ayaka ; Tanikawa, Ken ; Shiratsuchi, Hideki ; Tokuda, Masaaki ; Matsui, Toshiro ; Nakamura, Tsuyoshi. / Dietary d-allose ameliorates hepatic inflammation in mice with non-alcoholic steatohepatitis. In: Food Science and Technology Research. 2017 ; Vol. 23, No. 2. pp. 319-327.
@article{7aa415f6c9ce4e5b99e5897831b5e09d,
title = "Dietary d-allose ameliorates hepatic inflammation in mice with non-alcoholic steatohepatitis",
abstract = "Nonalcoholic steatohepatitis (NASH) is characterized by excess lipid accumulation and inflammation in hepatocytes. In this study, to provide insight into the preventive effects of d-allose, a rare sugar, on the onset of NASH, we designed animal experiments using male STAM mice treated with streptozotocin and fed a high-fat diet (HFD). Experiments were initiated when the mice reached 5 weeks of age and lasted 3 weeks. After the 3-week protocol, mice fed the HFD containing d-allose exhibited significantly decreased serum alanine aminotransferase levels, hepatic lipid accumulation and inflammation, and improved nonalcoholic fatty liver disease activity score compared to mice fed HFD without d-allose ( p < 0.05). Further, hepatic mRNA expression of sterol regulatory element binding protein-1 (Srebp-1) and monocyte chemotactic protein-1 (Mcp-1) was lower in mice fed d-allose. These results suggested that d-allose prevented NASH by blocking hepatic lipid accumulation and progressive inflammation.",
author = "Ryoko Yamamoto and Ayaka Iida and Ken Tanikawa and Hideki Shiratsuchi and Masaaki Tokuda and Toshiro Matsui and Tsuyoshi Nakamura",
year = "2017",
month = "1",
day = "1",
doi = "10.3136/fstr.23.319",
language = "English",
volume = "23",
pages = "319--327",
journal = "Food Science and Technology Research",
issn = "1344-6606",
publisher = "Japanese Society for Food Science and Technology",
number = "2",

}

TY - JOUR

T1 - Dietary d-allose ameliorates hepatic inflammation in mice with non-alcoholic steatohepatitis

AU - Yamamoto, Ryoko

AU - Iida, Ayaka

AU - Tanikawa, Ken

AU - Shiratsuchi, Hideki

AU - Tokuda, Masaaki

AU - Matsui, Toshiro

AU - Nakamura, Tsuyoshi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Nonalcoholic steatohepatitis (NASH) is characterized by excess lipid accumulation and inflammation in hepatocytes. In this study, to provide insight into the preventive effects of d-allose, a rare sugar, on the onset of NASH, we designed animal experiments using male STAM mice treated with streptozotocin and fed a high-fat diet (HFD). Experiments were initiated when the mice reached 5 weeks of age and lasted 3 weeks. After the 3-week protocol, mice fed the HFD containing d-allose exhibited significantly decreased serum alanine aminotransferase levels, hepatic lipid accumulation and inflammation, and improved nonalcoholic fatty liver disease activity score compared to mice fed HFD without d-allose ( p < 0.05). Further, hepatic mRNA expression of sterol regulatory element binding protein-1 (Srebp-1) and monocyte chemotactic protein-1 (Mcp-1) was lower in mice fed d-allose. These results suggested that d-allose prevented NASH by blocking hepatic lipid accumulation and progressive inflammation.

AB - Nonalcoholic steatohepatitis (NASH) is characterized by excess lipid accumulation and inflammation in hepatocytes. In this study, to provide insight into the preventive effects of d-allose, a rare sugar, on the onset of NASH, we designed animal experiments using male STAM mice treated with streptozotocin and fed a high-fat diet (HFD). Experiments were initiated when the mice reached 5 weeks of age and lasted 3 weeks. After the 3-week protocol, mice fed the HFD containing d-allose exhibited significantly decreased serum alanine aminotransferase levels, hepatic lipid accumulation and inflammation, and improved nonalcoholic fatty liver disease activity score compared to mice fed HFD without d-allose ( p < 0.05). Further, hepatic mRNA expression of sterol regulatory element binding protein-1 (Srebp-1) and monocyte chemotactic protein-1 (Mcp-1) was lower in mice fed d-allose. These results suggested that d-allose prevented NASH by blocking hepatic lipid accumulation and progressive inflammation.

UR - http://www.scopus.com/inward/record.url?scp=85046321289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046321289&partnerID=8YFLogxK

U2 - 10.3136/fstr.23.319

DO - 10.3136/fstr.23.319

M3 - Article

VL - 23

SP - 319

EP - 327

JO - Food Science and Technology Research

JF - Food Science and Technology Research

SN - 1344-6606

IS - 2

ER -